July 7 (Reuters) - FDA:
* FDA APPROVES NEW THERAPY FOR MYELODYSPLASTIC SYNDROMES THAT CAN BE TAKEN AT HOME
* FDA - APPROVED INQOVI TABLETS FOR TREATMENT OF ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES & CHRONIC MYELOMONOCYTIC LEUKEMIA
* FDA - GRANTED APPROVAL OF INQOVI TO ASTEX PHARMACEUTICALS, INC., A SUBSIDIARY OF OTSUKA PHARMACEUTICAL CO. LTD Source text: (bit.ly/2VZadRg) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.